BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38482236)

  • 1. Clinicopathological features and prognoses in younger and older patients with mismatch repair defects colorectal cancer: a retrospective comparative cohort study.
    Zhang J; Li S; Ma P; Zhang J; Cao Y; Liu C; Zhang X; Li Z; Li C; Zhao Y
    J Gastrointest Oncol; 2024 Feb; 15(1):260-270. PubMed ID: 38482236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of clinicopathological features and prognosis of sporadic synchronous multiple primary colorectal cancers].
    Qin ZF; Xu GH; Zhou SQ; Zheng PW; Zhu YP; Ju HX; Li DC; Ma DN
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Dec; 26(12):1171-1178. PubMed ID: 38110279
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative Effectiveness of Immune Checkpoint Inhibitors vs Chemotherapy in Patients With Metastatic Colorectal Cancer With Measures of Microsatellite Instability, Mismatch Repair, or Tumor Mutational Burden.
    Quintanilha JCF; Graf RP; Fisher VA; Oxnard GR; Ellis H; Panarelli N; Lin DI; Li G; Huang RSP; Ross JS; Myer PA; Klempner SJ
    JAMA Netw Open; 2023 Jan; 6(1):e2252244. PubMed ID: 36689222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications.
    Marginean EC; Melosky B
    Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch Repair.
    Ratovomanana T; Cohen R; Svrcek M; Renaud F; Cervera P; Siret A; Letourneur Q; Buhard O; Bourgoin P; Guillerm E; Dorard C; Nicolle R; Ayadi M; Touat M; Bielle F; Sanson M; Le Rouzic P; Buisine MP; Piessen G; Collura A; Fléjou JF; de Reyniès A; Coulet F; Ghiringhelli F; André T; Jonchère V; Duval A
    Gastroenterology; 2021 Sep; 161(3):814-826.e7. PubMed ID: 33992635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Institutional Universal Microsatellite-Instability (MSI) Reflex Testing on Molecular Profiling Differences Between Younger and Older Patients with Colorectal Cancer.
    Altshuler E; Franke AJ; Skelton WP; Feely M; Wang Y; Lee JH; Read T; Terracina K; Lou XY; Dai Y; George TJ
    Clin Colorectal Cancer; 2023 Mar; 22(1):153-159. PubMed ID: 36319582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Concordance Between Deficient Mismatch Repair and Microsatellite Instability Testing and Their Association with Clinicopathological Features in Colorectal Cancer.
    Bai H; Wang R; Cheng W; Shen Y; Li H; Xia W; Ding Z; Zhang Y
    Cancer Manag Res; 2020; 12():2863-2873. PubMed ID: 32425600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rate of dissemination and prognosis in early and advanced stage colorectal cancer based on microsatellite instability status: systematic review and meta-analysis.
    Toh JWT; Phan K; Reza F; Chapuis P; Spring KJ
    Int J Colorectal Dis; 2021 Aug; 36(8):1573-1596. PubMed ID: 33604737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of microsatellite instability and/or mismatch repair deficiency stage III colon cancer patients after disease recurrence following adjuvant treatment: results of an ACCENT pooled analysis of seven studies.
    Taieb J; Shi Q; Pederson L; Alberts S; Wolmark N; Van Cutsem E; de Gramont A; Kerr R; Grothey A; Lonardi S; Yoshino T; Yothers G; Sinicrope FA; Zaanan A; André T
    Ann Oncol; 2019 Sep; 30(9):1466-1471. PubMed ID: 31268130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of mismatch repair or microsatellite status on the prognosis and efficacy to chemotherapy in metastatic colorectal cancer patients: A bi-institutional, propensity score-matched study.
    Yao YC; Jin Y; Lei XF; Wang ZX; Zhang DS; Wang FH; Li YH; Xu RH; Wang F
    J Cancer; 2022; 13(9):2912-2921. PubMed ID: 35912009
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic and predictive significance of microsatellite instability in stage II colorectal carcinoma: An 8-year study from a tertiary center in South India.
    Paulose RR; Ail DA; Biradar S; Vasudevan A; Sundaram KR
    Indian J Cancer; 2019; 56(4):302-308. PubMed ID: 31607697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population-Based Multicenter Study.
    He EY; Hawkins NJ; Mak G; Roncolato F; Goldstein D; Liauw W; Clingan P; Chin M; Ward RL
    Oncologist; 2016 May; 21(5):618-25. PubMed ID: 27009937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-Agent Neoadjuvant Immunotherapy With a PD-1 Antibody in Locally Advanced Mismatch Repair-Deficient or Microsatellite Instability-High Colorectal Cancer.
    Pei F; Wu J; Zhao Y; He W; Yao Q; Huang M; Huang J
    Clin Colorectal Cancer; 2023 Mar; 22(1):85-91. PubMed ID: 36528470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concordance between microsatellite instability and mismatch repair protein expression in colorectal cancer and their clinicopathological characteristics: a retrospective analysis of 502 cases.
    Ye M; Ru G; Yuan H; Qian L; He X; Li S
    Front Oncol; 2023; 13():1178772. PubMed ID: 37427134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsatellite Status Detection of Colorectal Cancer: Evaluation of Inconsistency between PCR and IHC.
    Chen J; Yan Q; Sun J; Wang Q; Tao Y; Xiao D; Xie B
    J Cancer; 2023; 14(7):1132-1140. PubMed ID: 37215453
    [No Abstract]   [Full Text] [Related]  

  • 16. Real-World Treatment Patterns and Clinical Outcomes for Standard of Care Regimens in Patients with Deficient MMR or MSI-High Metastatic Colorectal and Non-Colorectal Cancer: A Retrospective Chart Review Study in France.
    Roset M; Amonkar M; Patel R; Lara N; Kothari S
    Adv Ther; 2022 Mar; 39(3):1215-1229. PubMed ID: 35025060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficient mismatch repair/microsatellite unstable colorectal cancer: Diagnosis, prognosis and treatment.
    Taieb J; Svrcek M; Cohen R; Basile D; Tougeron D; Phelip JM
    Eur J Cancer; 2022 Nov; 175():136-157. PubMed ID: 36115290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological characteristics of high microsatellite instability/mismatch repair-deficient colorectal cancer: A narrative review.
    Mei WJ; Mi M; Qian J; Xiao N; Yuan Y; Ding PR
    Front Immunol; 2022; 13():1019582. PubMed ID: 36618386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes for Metastatic Colorectal Cancer Based on Microsatellite Instability: Results from the South Australian Metastatic Colorectal Cancer Registry.
    Chong LC; Townsend AR; Young J; Roy A; Piantadosi C; Hardingham JE; Roder D; Karapetis C; Padbury R; Maddern G; Moore J; Price TJ
    Target Oncol; 2019 Feb; 14(1):85-91. PubMed ID: 30659494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
    Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
    BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.